2014 Highlights of ASH in North America Meeting

Emerging effective treatment options for salvage therapy in Hodgkin lymphoma were described by Anas Younes, MD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, New York, at th...

myelodysplastic syndromes

Caroline Helwick / May 15, 2014 / 2014 Highlights of ASH in North America Meeting

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Most recent advances in the management of myelodysplastic syndrome (MDS) are in the area of genetics, according to Steven Gore, MD, of Yale University School of Medicine, New Haven. “New genomics res...

Jan

Today In Oncology

Survival With Combined Modality Therapy vs Chemotherapy Alone in Early-Stage Pediatric Hodgkin Lymphoma

Patient-Reported Outcomes With Nivolumab Plus Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma

Oncologist Survey on Knowledge About LGBTQ Patients With Cancer

2019 GI Cancers Symposium: Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Short-Course Radiation vs Concurrent Chemoradiation

2019 GI Cancers Symposium: Is Adjuvant HIPEC Effective in Reducing the Risk of Peritoneal Metastases in Patients With Colon Cancer?

;

2014 Highlights of ASH in North America Meeting

Better Options Emerging for Salvage Therapy in Hodgkin Lymphoma

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Survival With Combined Modality Therapy vs Chemotherapy Alone in Early-Stage Pediatric Hodgkin Lymphoma

Patient-Reported Outcomes With Nivolumab Plus Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma

Oncologist Survey on Knowledge About LGBTQ Patients With Cancer

2019 GI Cancers Symposium: Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Short-Course Radiation vs Concurrent Chemoradiation

2019 GI Cancers Symposium: Is Adjuvant HIPEC Effective in Reducing the Risk of Peritoneal Metastases in Patients With Colon Cancer?

Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects

Comorbidities and Cancer Clinical Trial Enrollment

Common Markers of Tumor Hypoxia Found Across Cancer Types

When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?

OlympiAD Trial: Olaparib in Metastatic Breast Cancer With Germline BRCA Mutation

Caroline Robert, MD, PhD, on Immunotherapy Toxicities: Expert Perspective

Michael Soike, MD, on Brain Metastases: Radiosurgery vs Radiotherapy

Betty R. Ferrell, PhD, on Quality of Life in the Era of Immunotherapy

Allison S. Betof Warner, MD, PhD, on Managing Immune-Related Adverse Events: Incorporating Guidelines

Roberto A. Leon-Ferre, MD, on Decreasing Hot Flashes: Results From an ACCRU Trial